ConductScience.org, home

Trial · NCT07907549

Content Interest, Neck Posture, and Discomfort During Smartphone Use

NCT07907549, Not applicable, Not yet recruiting, Karabuk University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Content Interest, Neck Posture, and Discomfort During Smartphone Use. Trials, record NCT07907549. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07907549

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Content Interest, Neck Posture, and Discomfort During Smartphone Use
NCT number
NCT07907549
Status
Not yet recruiting
Phases
Not applicable
Enrollment
100 participants, estimated
Lead sponsor
Karabuk University
Conditions
Neck Discomfort During Smartphone Use
Interventions
Preferred/High-Interest Smartphone Video Viewing, Neutral/Lower-Interest Smartphone Video Viewing
First posted
2026-10-30
Last updated
2026-10-30

Source ClinicalTrials.gov

Registered outcomes9

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNeck Discomfort at Minute 30At minute 30 of each of two sessions, separated by 48-72 hours
Perceived neck discomfort measured with the 0-10 Borg CR-10 discomfort scale, where 0 indicates no discomfort and higher scores indicate greater discomfort. The primary endpoint is the within-participant difference between preferred/high-interest and neutral/lower-interest content conditions at minute 30.
SecondaryNeck Discomfort Over TimeBaseline and minutes 10, 20, and 30 in each session; sessions 48-72 hours apartRepeated perceived neck discomfort on the 0-10 Borg CR-10 scale. Higher values indicate greater discomfort.
SecondaryRight and Left Shoulder DiscomfortBaseline and minutes 10, 20, and 30 in each session; sessions 48-72 hours apartRight and left shoulder discomfort measured separately using the 0-10 Borg CR-10 scale. Higher values indicate greater discomfort; sides are analyzed separately.
SecondaryNeck Flexion AngleMinutes 0, 5, 10, 15, 20, 25, and 30 of each session; sessions 48-72 hours apartSagittal neck flexion angle in degrees between the tragus-C7 line and vertical, measured from standardized video frames using Kinovea.
SecondaryTrunk AngleMinutes 0, 5, 10, 15, 20, 25, and 30 of each session; sessions 48-72 hours apartSagittal trunk angle in degrees formed by the C7-T12 and T12-greater trochanter lines, measured using Kinovea from standardized video frames.
SecondaryTask Engagement and FlowImmediately after each 30-minute session; sessions 48-72 hours apartTask engagement and flow assessed with the Turkish Flow Short Scale. The flow score reflects absorption and fluency during the video-viewing task; higher flow scores indicate greater flow experience.
SecondaryInterest and EnjoymentImmediately after each 30-minute session; sessions 48-72 hours apart
Interest/enjoyment assessed with the interest/enjoyment subscale of the Turkish Intrinsic Motivation Inventory. Higher scores indicate greater intrinsic interest and enjoyment; used as a manipulation check.
SecondaryEmotional Valence and ArousalImmediately after each 30-minute session; sessions 48-72 hours apart
Self-Assessment Manikin pictorial ratings of emotional valence and arousal, reported separately. Valence reflects unpleasant-to-pleasant affect; arousal reflects calm-to-excited activation. Used to characterize the emotional response to content.
OtherPressure Pain ThresholdBefore and immediately after each 30-minute session; sessions separated by 48-72 hours
Exploratory mechanistic outcome measured in kPa with calibrated digital algometry at the right and left upper trapezius and dominant tibialis anterior. A 1 cm2 probe is applied perpendicular to the skin at approximately 30 kPa/s until first pain. Three readings per site are averaged, with 30-60 seconds between readings. Higher values indicate lower pressure pain sensitivity. Sites are analyzed separately.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07907549

GET https://conductscience.org/api/trials/v1/NCT07907549/registered